Skip to content

Insider · CIK 0001802710

Primit Parikh

ceopresidentofficerdirectorcoo

Files at TGAN (Transphorm, Inc.). First filing Nov 21, 2022, latest Mar 4, 2024.

In brief

Primit Parikh files SEC Form 4 as CEO, president, director and COO at TGAN (Transphorm, Inc.). Since Nov 21, 2022, Primit Parikh has reported 0 open-market buys worth $0 and 4 open-market sells worth $113k, the latest filed on Mar 4, 2024.

A track record needs three past buys with six months of prices behind them; Primit Parikh has 0, so none is measured yet.

The newest scored trade: sold $29k of TGAN on Feb 29, 2024, filed Mar 4, 2024, scored 45 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $113k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
45Moderate
TGANsell 3
Transphorm, Inc.
$29k
6,000 shares
-1%-
35Weak
TGANsell 4
Transphorm, Inc.
$20k
3,500 shares
-1%-
20Weak
TGANsell 4
Transphorm, Inc.
$13k
2,000 shares
-1%-
42Moderate
TGANsell 4
Transphorm, Inc.
$51k
8,927 shares
-4%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Mar 1, 2024 TGAN
Transphorm, Inc.
6,000
0.01% of outstanding
$29kFeb 29, 2024none

Transactions

Every row this insider has filed, 18 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Common Stock
-489,310--0Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-80,891$0.00$00Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-207,228$0.00$00Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-6,870$0.00$00Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-105,000$0.00$00Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-1,563$0.00$00Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-4,655$0.00$00Jun 20, 2024
Jun 20, 2024TGAN
Transphorm, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
-192,000$0.00$00Jun 20, 2024
Feb 29, 2024TGAN
Transphorm, Inc.
SOpen-market sale
Common Stock
-6,000$4.80$29k489,310Mar 4, 2024
Jan 1, 2024TGAN
Transphorm, Inc.
FTax withholding
Common Stock
-6,780$3.65$25k495,310Jan 3, 2024
Nov 17, 2023TGAN
Transphorm, Inc.
FTax withholding
Common Stock
-8,069$2.77$22k502,090Nov 21, 2023
Dec 9, 2022TGAN
Transphorm, Inc.
AGrant or award
Stock Option (right to buy)derivative
+4,655$0.00$04,655Dec 13, 2022
Nov 29, 2022TGAN
Transphorm, Inc.
SOpen-market sale
Common Stock
-1,852$6.04$11k234,706Dec 1, 2022
Nov 30, 2022TGAN
Transphorm, Inc.
SOpen-market sale
Common Stock
-1,648$5.63$9,285233,058Dec 1, 2022
Nov 23, 2022TGAN
Transphorm, Inc.
MOption exercise
Common Stock
+1,000$4.34$4,340238,558Nov 28, 2022
Nov 23, 2022TGAN
Transphorm, Inc.
SOpen-market sale
Common Stock
-2,000$6.64$13k236,558Nov 28, 2022
Nov 23, 2022TGAN
Transphorm, Inc.
MOption exercise
Stock Option (right to buy)derivative
-1,000$0.00$080,891Nov 28, 2022
Nov 17, 2022TGAN
Transphorm, Inc.
SOpen-market sale
Common Stock
-8,927$5.67$51k237,558Nov 21, 2022

Questions about Primit Parikh

Answered from the filings on this page, as of the latest one.

Is Primit Parikh buying or selling?

Not in the last 12 months. Primit Parikh's latest open-market trade on SEC Form 4 was sold $29k of TGAN on Feb 29, 2024.

How did Primit Parikh's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Primit Parikh has 0.

Where does Primit Parikh file Form 4?

Primit Parikh has filed Form 4 at TGAN (Transphorm, Inc.) as President and COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Primit Parikh: insider trades and track record | InsiderTell